Pharma Investment Trend Report: What We're Watching in 2023 | King & Spalding
2022 was a big year for the pharmaceutical and biotechnology sectors. Novel technologies emerged at a rapid clip. The Food and Drug Administration (“FDA” or the “Agency”) approved over...